Metropolitan Life Insurance Company (MetLife)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,624
| Closed | -$838K | – | 2675 |
|
|
2021
Q4 | $838K | Buy |
5,624
+17
| +0.3% | +$2.53K | 0.01% | 1095 |
|
|
2021
Q3 | $816K | Buy |
+5,607
| New | +$816K | 0.01% | 1114 |
|
|
2021
Q2 | – | Sell |
-4,174
| Closed | -$755K | – | 2883 |
|
|
2021
Q1 | $755K | Sell |
4,174
-187
| -4% | -$33.8K | 0.01% | 1144 |
|
|
2020
Q4 | $618K | Sell |
4,361
-85
| -2% | -$12K | 0.01% | 1229 |
|
|
2020
Q3 | $554K | Buy |
4,446
+124
| +3% | +$15.5K | 0.01% | 1149 |
|
|
2020
Q2 | $386K | Buy |
+4,322
| New | +$386K | 0.01% | 1396 |
|